Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster https://ift.tt/vJWndzw

The Drugs Controller General of India(DCGI) on Tuesday has given emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SCTkZdu
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.